Related Experiment Video
Updated: May 12, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Direct interaction between surface β1,4-galactosyltransferase 1 and epidermal growth factor receptor (EGFR) inhibits
Wenqing Tang1, Shuqiang Weng, Si Zhang
1Department of Gastroenterology and Hepatology of Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Abstract:
Our previous studies showed that cell surface β1,4-galactosyltransferase 1 (β1,4GT1) negatively regulated cell survival through inhibition and modulation of the epidermal growth factor receptor (EGFR) signaling pathway in human hepatocellular carcinoma (HCC) SMMC-7721 cells. However, the underlying mechanism remains unclear. Here we demonstrated that β1,4-galactosyltransferase 1 (β1,4GT1) interacted with EGFR in vitro by GST pull-down analysis. Furthermore, we demonstrated that β1,4GT1 bound to EGFR in vivo by co-immunoprecipitation and determined the co-localization of β1,4GT1 and EGFR on the cell surface via confocal laser scanning microscopy analysis. Finally, using (125)I-EGF binding experiments and Western blot analysis, we found that overexpression of β1,4GT1 inhibited (125)I-EGF binding to EGFR, and consequently reduced the levels of EGFR dimerization and phosphorylation. In contrast, RNAi-mediated knockdown of β1,4GT1 increased the levels of EGFR dimerization and phosphorylation. These data suggest that cell surface β1,4GT1 interacts with EGFR and inhibits EGFR activation.
Insights
Cell surface galactosyltransferase 1 (β1,4GT1) interacts with epidermal growth factor receptor (EGFR) in hepatocellular carcinoma cells. This interaction inhibits EGFR activation, impacting cell survival signaling pathways.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Previous studies indicated cell surface β1,4-galactosyltransferase 1 (β1,4GT1) negatively regulates cell survival in hepatocellular carcinoma (HCC) by modulating the epidermal growth factor receptor (EGFR) pathway.
- The precise molecular mechanism underlying this regulation remained unclear.
Purpose of the Study:
- To elucidate the interaction mechanism between β1,4GT1 and EGFR in HCC.
- To determine how β1,4GT1 influences EGFR signaling and activation.
Main Methods:
- GST pull-down assays for in vitro interaction.
- Co-immunoprecipitation for in vivo binding confirmation.
- Confocal laser scanning microscopy for co-localization studies.
- (125)I-EGF binding assays and Western blot analysis to assess EGFR activation.
Main Results:
- β1,4GT1 was shown to interact with EGFR both in vitro and in vivo.
- Co-localization of β1,4GT1 and EGFR was observed on the cell surface.
- Overexpression of β1,4GT1 inhibited EGF binding to EGFR, reducing EGFR dimerization and phosphorylation.
- Knockdown of β1,4GT1 led to increased EGFR dimerization and phosphorylation.
Conclusions:
- Cell surface β1,4GT1 directly interacts with EGFR.
- This interaction inhibits EGFR activation, suggesting a novel regulatory mechanism in HCC cell signaling and survival.
Related Concept Videos
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
TGF - β Signaling Pathway
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
